NASDAQ:GALT

Galectin Therapeutics, Inc Earning Date

USA |NASDAQ |USD

GALT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.18 $-0.15 $-0.10
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $0.00 $0.00 $0.00

Galectin Therapeutics, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

GALT Earnings Date & History Chart

GALT Earnings & Revenue Forecast

GALT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.17 $-0.17 $-0.17
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.60 $-0.60 $-0.60
Dec 2022 1 $-0.70 $-0.70 $-0.70

GALT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.17 $-0.17 $-0.17
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.60 $-0.65 $-0.65
Dec 2022 0 / 0 $-0.70 $-0.66 $-0.66

GALT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.00 $0.00 $0.00
Dec 2022 1 $0.00 $0.00 $0.00

GALT Earnings Date & Revenue History

GALT Earnings History

|
Show More
Show More

GALT Revenue History

|
Show More
Show More

Galectin Therapeutics, Inc Next Earnings Date & Report

GALT Next Earnings Date & Report Preview: Sep 2021 (FQ)

GALT's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 1 analysts, the average EPS estimation for Galectin Therapeutics, Inc's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.18, and a high estimation of $-0.18.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.19, and the 3 month trend is $-0.19.

Based on 1 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Galectin Therapeutics, Inc Previous Earnings Dates & Reports

GALT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Galectin Therapeutics, Inc's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

GALT's earnings per share (EPS) was $-0.15, beating the consensus analysts forecast of $-0.18 by 16.67%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 36.36%, and lower than the same period a year before (Jun 2020) by 36.36%.

Revenues were $0.00.

The company reported a net income of $-8.45M.

Free cash flow for the quarter was $-5.98M , compared to $-6.38M last quarter and $-2.60M a year before.

GALT ended the quarter with $9.67M in total debt, an increase of 22933.33% compared to the previous quarter, and an increase of 13336.11% compared to the same quarter a year before.

GALT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Galectin Therapeutics, Inc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

GALT's earnings per share (EPS) was $-0.40, beating the consensus analysts forecast of $-0.43 by -6.98% , and higher than the previous year's EPS (Dec 2019) by -6.98%.

Revenues were $0.00.

The company reported a net income of $-23.46M.

Galectin Therapeutics, Inc reported a free cash flow of $-20.60M for its fiscal year, compared to $-10.85M a year ago.